Skip to main content

Table 2 Clinical and biochemical parameters at the start of combined therapy with PD and HD

From: Clinical efficacy of combined therapy with peritoneal dialysis and hemodialysis

Author, year

SBP [mmHg]

DBP [mmHg]

Urine volume [mL/day]

UF volume [mL/day]

BUN [mg/dL]

Cr [mg/dL]

β2m [mg/L]

D/P Cr

Weekly Kt/V

Weekly Ccr [L/week/1.73 m2]

Hashimoto, 2000 [9]

        

1.98 ± 0.28

58.6 ± 10.5

Agarwal, 2003 [12]

        

1.96 ± 0.51

 

Kawanishi, 2006 [14]

152 ± 25

 

151 ± 25

794 ± 447

63.0 ± 18.2

13.1 ± 3.3

35.8 ± 14.3

 

1.86 ± 0.52

 

Hoshi, 2006 [15]

141 ± 5

72 ± 4

  

76.4 ± 7.8

13.5 ± 0.8

    

Kawanishi, 2007 [16]

      

33.3 ± 11.3

 

1.55 ± 0.4

42.0 ± 7.7

Matsuo, 2010 [18]

145 ± 22

84 ± 17

253 ± 405

907 ± 579

61 ± 16

13.5 ± 3.6

35.9 ± 7.5

0.65 ± 0.11

 

50.2 ± 5.3

Tanaka, 2011 [19]

156 ± 17

 

200 (0–900)

  

12.2 ± 2.8

  

2.2 ± 0.4

 

Maruyama, 2014 [21]

144 ± 22

80 ± 14

150 (0–2000)

1000 (−500–2350)

59.2 ± 14.6

12.9 ± 3.4

34.4 ± 7.2

0.67 ± 0.11

1.8 ± 0.4

49.9 ± 13.1

  1. PD peritoneal dialysis, HD hemodialysis, SBP systolic blood pressure, DBP diastolic blood pressure, UF ultrafiltration, BUN blood urea nitrogen, Cr creatinine, β2m β2 microglobulin, D/P Cr dialysate-to-plasma ratio of creatinine, Ccr creatinine clearance